Interestingly, T. aphylla treatment resulted in a noteworthy lessening in NF-κB expression, indicative of its capacity to downregulate NF-κB gene expression and counteract the inflammatory cascade in PD. This evidence concerns the gene NFKB1 and Parkinson disease.